Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT05511324
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05510427
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT05501054
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸Duke Cancer Institute, Durham, North Carolina, United States
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT05497024
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT05497778
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT05496972
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05495464
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05488444
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 188
- Registration Number
- NCT05474846
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05474352
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath